# AstraZeneca stock performance and earnings

> Developing situation record from CLSTR: https://clstr.news/situations/astrazeneca-stock-performance-and-earnings
> Updated: 2026-11-02T07:01:48.000Z. Sources: 5. Developments: 3.

AstraZeneca shares initially saw a slight increase of 0.2% to 118.90 GBP following reports of a 5.84% year-over-year increase in quarterly revenue. The company also noted the expansion of its breast cancer drug, Enhertu, in England.

By November, the company experienced a significant upward trend, with reports noting a 7.02% increase to $186.65. Technical analysis indicated the stock broke above its 200-day moving average, signaling a recovery from previous lows despite indicators suggesting the stock was in overbought territory.

As of November 2026, AstraZeneca has reiterated a long-term goal to reach $80 billion in full-year revenue by 2030. To achieve this, the company is implementing a “Reshaping for Sustainable Growth” program designed to save $1.5 billion annually. CEO Pascal Soriot stated that these savings will be reinvested into drug research, noting that artificial intelligence will play a key role in increasing operational efficiency and supporting the company’s pipeline.

## Timeline

### 2026-11-02: AstraZeneca shares rise following positive quarterly results

AstraZeneca shares rose significantly following positive quarterly results, breaking above key technical moving averages.

2 sources. https://clstr.news/cluster/astrazeneca-shares-rise-following-positive-quarterly-results

### 2026-11-01: AstraZeneca, BioMarin, and Marriott prepare for quarterly earnings reports

AstraZeneca, BioMarin Pharmaceutical, and Marriott are all approaching key quarterly earnings reports amid varying market expectations and strategic shifts.

3 sources. https://clstr.news/cluster/astrazeneca-biomarin-and-marriott-prepare-for-quarterly-earnings-reports

### 2026-10-04: AST SpaceMobile and AstraZeneca see stock movement amid market shifts

AST SpaceMobile faces a B. Riley downgrade due to market competition and operational risks, while AstraZeneca shares rise amid revenue growth and the expansion of its breast cancer drug Enhertu in England.

2 sources. https://clstr.news/cluster/ast-spacemobile-and-astrazeneca-see-stock-movement-amid-market-shifts

---
Cite as: AstraZeneca stock performance and earnings. CLSTR, https://clstr.news/situations/astrazeneca-stock-performance-and-earnings